These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Current progress in cystic fibrosis: is this a disease elusive to therapy? Brown C Pulm Pharmacol Ther; 2008 Aug; 21(4):585-7. PubMed ID: 18313958 [No Abstract] [Full Text] [Related]
8. Making precision medicine personal for cystic fibrosis. Manfredi C; Tindall JM; Hong JS; Sorscher EJ Science; 2019 Jul; 365(6450):220-221. PubMed ID: 31320522 [No Abstract] [Full Text] [Related]
15. Population screening of F508del (DeltaF508), the most frequent mutation in the CFTR gene associated with cystic fibrosis in Argentina. Roqué M; Godoy CP; Castellanos M; Pusiol E; Mayorga LS Hum Mutat; 2001 Aug; 18(2):167. PubMed ID: 11462248 [TBL] [Abstract][Full Text] [Related]
17. Innovations in the treatment of cystic fibrosis: outriders for the treatment of diseases with other genetic defects? Schubert-Zsilavecz M; Merk D Future Med Chem; 2011 Dec; 3(16):1969-70. PubMed ID: 22098344 [No Abstract] [Full Text] [Related]
18. [Challenges of personalized medicine for cystic fibrosis]. Corvol H; Taytard J; Tabary O; Le Rouzic P; Guillot L; Clement A Arch Pediatr; 2015 Jul; 22(7):778-86. PubMed ID: 26021452 [TBL] [Abstract][Full Text] [Related]
20. Editorial: Emerging Molecular Targets for the Treatment of Cystic Fibrosis. Yang Z; Sun F; Li C Curr Drug Targets; 2015; 16(9):922. PubMed ID: 26323277 [No Abstract] [Full Text] [Related] [Next] [New Search]